Blog

Focus on Islamic State and Libya as NATO foreign ministers meet

By Adrian Croft ANTALYA, Turkey (Reuters) – Preoccupied for more than a year by the Ukraine crisis, NATO foreign ministers meeting in Turkey this week will focus on instability on the alliance’s southern flank, ranging from Islamic State in Iraq and Syria to turmoil in Libya. By meeting in Turkey, which shares a 1,200 km (750-mile) border with Iraq and Syria, NATO hopes to show it is responsive to the

Mozambique's economy to grow 7% in 2015: IMF

The International Monetary Fund said Tuesday it expected Mozambique’s economy to grow seven percent this year, thanks to investment in the vast northeastern Rovuma gas fields. “Mozambique’s economic performance remains robust and stronger than most other Sub-Saharan African countries,” said Alex Segura-Ubiergo, who led an IMF team on a two-week trip to Mozambique. Mozambique is on the cusp of becoming the world’s third largest exporter of liquefied natural gas after

Sick in winter but healthy in summer? Blame your genes

Nearly a quarter of our genes change how active they are according to the season, which may explain why people are more prone to illness in winter rather than summer, scientists said Tuesday. In a study published in the journal Nature Communications, the researchers said they were stunned by just how much of our genetic code is affected by the time of year. Out of 22,822 genes the researchers analysed,

Clarification: Gas Drilling-Water Contamination story

In a story May 4, The Associated Press reported on research that found drilling fluids likely leaked into a drinking water supply in Pennsylvania. The story should have noted that one of the study’s authors, Garth T. Llewellyn, was a consultant for affected homeowners who sued the driller. That information was not included on a pre-publication version of the study provided to reporters by the journal Proceedings of the National

Bavarian Nordic gets 50 million euro EIB loan for Ebola vaccine

By Sabina Zawadzki COPENHAGEN (Reuters) – Bavarian Nordic has received a 50 million euro ($56 million) loan from the European Investment Bank (EIB) to help it develop a vaccine against Ebola, which has claimed 11,000 lives in a pandemic in Western Africa. Some of the loan can also be used to develop the Danish company’s prostate cancer immunotherapy, which industry experts have said could be a ground-breaker in the treatment